MedTrace Logo

Penn Biobank Return of Research Results Program

NCT04242667 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2024-07-01

No results posted yet for this study

Summary

The overall goal of the proposed research is to assess the feasibility of a randomized study evaluating the non-inferiority of an electronic Health (e-Health) delivery alternative (e.g. private web portal) as compared to return of actionable genetic research results with a genetic counselor.

Conditions

Interventions

BEHAVIORAL

e-Health (web-based) disclosure portal

Patient uses secure web-based portal to access genetic research results

BEHAVIORAL

Provider mediated disclosure

Patient has disclosure of genetic research result by a provider (genetic counselor)

Sponsors & Collaborators

  • Fox Chase Cancer Center

    collaborator OTHER

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Angela Bradbury, M.D. · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2023-04-11
Completion
2023-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04242667 on ClinicalTrials.gov